CD274 and breast carcinoma: This work highlights that controlled and accurate delivery of cytotoxic agents with “ICD induction” functions by macrophage-mediated delivery combined with anti-PD-L1 would be a promising therapeutic strategy for efficient synchronous therapy of primary and bone metastatic breast cancer.